---
title: "U.S.-Listed Chinese ADRs Mostly Fall; Yunmi Surges 25.93%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298656980.md"
description: "U.S.-listed Chinese ADRs mostly declined overnight, with Yunmi rising 25.93% to $1.36, according to ETNet. Among major names, Alibaba fell 0.77% to $108.56, Baidu dropped 1.56% to $90.59, Bilibili lost 2.77% to $15.47, Tencent slipped 1.65% to $53.79 and PDD eased 0.98% to $77.84. In other sectors, Li Auto fell 2.18% to $11.65, Nio declined 3.24% to $3.58 and XPeng dropped 2.18% to $10.34. BeiGene fell 2.62% to $341.80, Hutchmed lost 3.32% to $13.12 and Zai Lab declined 3.63% to $24.17. The dollar was quoted at HK$7.8407."
datetime: "2026-09-11T00:05:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298656980.md)
  - [en](https://longbridge.com/en/news/298656980.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298656980.md)
generator: "portal-rs"
---

# U.S.-Listed Chinese ADRs Mostly Fall; Yunmi Surges 25.93%

U.S.-listed Chinese ADRs mostly declined overnight, with Yunmi rising 25.93% to $1.36, according to ETNet. Among major names, Alibaba fell 0.77% to $108.56, Baidu dropped 1.56% to $90.59, Bilibili lost 2.77% to $15.47, Tencent slipped 1.65% to $53.79 and PDD eased 0.98% to $77.84. In other sectors, Li Auto fell 2.18% to $11.65, Nio declined 3.24% to $3.58 and XPeng dropped 2.18% to $10.34. BeiGene fell 2.62% to $341.80, Hutchmed lost 3.32% to $13.12 and Zai Lab declined 3.63% to $24.17. The dollar was quoted at HK$7.8407.

### Related Stocks

- [ZLAB.US](https://longbridge.com/en/quote/ZLAB.US.md)
- [BGNE.US](https://longbridge.com/en/quote/BGNE.US.md)
- [HCM.US](https://longbridge.com/en/quote/HCM.US.md)
- [PDD.US](https://longbridge.com/en/quote/PDD.US.md)
- [BILI.US](https://longbridge.com/en/quote/BILI.US.md)
- [PDDL.US](https://longbridge.com/en/quote/PDDL.US.md)
- [KPDD.US](https://longbridge.com/en/quote/KPDD.US.md)
- [09626.HK](https://longbridge.com/en/quote/09626.HK.md)
- [06160.HK](https://longbridge.com/en/quote/06160.HK.md)
- [09688.HK](https://longbridge.com/en/quote/09688.HK.md)
- [688235.CN](https://longbridge.com/en/quote/688235.CN.md)
- [VIOT.US](https://longbridge.com/en/quote/VIOT.US.md)
- [BABA.US](https://longbridge.com/en/quote/BABA.US.md)
- [09988.HK](https://longbridge.com/en/quote/09988.HK.md)
- [BIDU.US](https://longbridge.com/en/quote/BIDU.US.md)
- [09888.HK](https://longbridge.com/en/quote/09888.HK.md)
- [TCEHY.US](https://longbridge.com/en/quote/TCEHY.US.md)
- [00700.HK](https://longbridge.com/en/quote/00700.HK.md)
- [LI.US](https://longbridge.com/en/quote/LI.US.md)
- [02015.HK](https://longbridge.com/en/quote/02015.HK.md)
- [NIO.US](https://longbridge.com/en/quote/NIO.US.md)
- [09866.HK](https://longbridge.com/en/quote/09866.HK.md)
- [XPEV.US](https://longbridge.com/en/quote/XPEV.US.md)
- [09868.HK](https://longbridge.com/en/quote/09868.HK.md)
- [00013.HK](https://longbridge.com/en/quote/00013.HK.md)
- [89988.HK](https://longbridge.com/en/quote/89988.HK.md)
- [HBBD.SG](https://longbridge.com/en/quote/HBBD.SG.md)
- [89888.HK](https://longbridge.com/en/quote/89888.HK.md)
- [80700.HK](https://longbridge.com/en/quote/80700.HK.md)
- [HTCD.SG](https://longbridge.com/en/quote/HTCD.SG.md)
- [TCTZF.US](https://longbridge.com/en/quote/TCTZF.US.md)
- [NIO.SG](https://longbridge.com/en/quote/NIO.SG.md)

## Related News & Research

- [Apple’s iPhone 18 Pro Quickly Falls Below Launch Price on China Platforms](https://longbridge.com/en/news/299034396.md)
- [What’s Next for Bilibili As Tencent Pivots From Shareholder To Creditor?](https://longbridge.com/en/news/298737598.md)
- [FDA Approves Tablet Form of Zanubrutinib for All Approved Indications](https://longbridge.com/en/news/298434766.md)
- [LI AUTO-W  Repurchases 679,600 Shares on Sep 11 for Approx. HKD31.274 Million](https://longbridge.com/en/news/298848756.md)
- [Bilibili prices unregistered sale of 6,976,760 shares at HK$ 115.38 each](https://longbridge.com/en/news/298298123.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**